BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Arthramid - ECPv6.15.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Arthramid
X-ORIGINAL-URL:https://arthramid.com/ww/
X-WR-CALDESC:Events for Arthramid
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Pacific/Auckland
BEGIN:STANDARD
TZOFFSETFROM:+1300
TZOFFSETTO:+1200
TZNAME:NZST
DTSTART:20250405T140000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1200
TZOFFSETTO:+1300
TZNAME:NZDT
DTSTART:20250927T140000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Pacific/Auckland:20251120T080000
DTEND;TZID=Pacific/Auckland:20251121T170000
DTSTAMP:20260424T114357
CREATED:20250917T234909Z
LAST-MODIFIED:20251106T004451Z
UID:10187-1763625600-1763744400@arthramid.com
SUMMARY:Contura Vet at London Vet Show
DESCRIPTION:Discover Arthramid at London Vet Show 2025\nJoin us at Europe’s premier veterinary event and discover how Arthramid® is transforming joint health across the globe.\nThe London Vet Show presents an exclusive opportunity for European veterinarians to explore the science behind Arthramid’s innovative 2.5% injectable polyacrylamide hydrogel (iPAAG) technology. As the first and only treatment designed to target the synovium directly\, Arthramid offers a new approach to managing osteoarthritis and joint lameness in both equine and canine patients. \nHear from Dr. Jason Lowe – Arthramid’s Chief Veterinary Officer and Managing Director in two mini lectures at the event: \nReframing 2.5%: iPAAG Insights Into the Mechanism and Medicine of Its Role in OA Therapy\nThursday 20 Nov 2025 | 14:00–15:00 \nRethinking OA Therapy: 2.5% iPAAG as a Novel OA Modulator\nwith Matt Brunke (VetDVM\, DACVSMR\, Fellow IAVRPT)\nFriday 21 Nov 2025 | 10:45–11:45 \n  \nDr. Lowe will be at the Nupsala stand (H10) throughout the event and is available to discuss: \n\nClinical applications and case selection for Arthramid\nLatest research findings from Colorado State University\nReal-world outcomes from veterinary practices across Europe\nIntegration of Arthramid into your treatment protocols\n\nWhether you’re looking to expand your joint health offerings or seeking evidence-based solutions for challenging lameness cases\, this is your chance to engage directly with the clinical expertise behind Arthramid’s success. \nDon’t miss this opportunity to advance your approach to joint health management.
URL:https://arthramid.com/ww/event/contura-at-london-vet-show/
LOCATION:London\, United Kingdom
CATEGORIES:CANINE,EQUINE,IN-PERSON
ATTACH;FMTTYPE=image/webp:https://arthramid.com/wp-content/uploads/LVS-2025-Logo.webp
END:VEVENT
END:VCALENDAR